grant
Effectiveness and Cost-effectiveness in Alzheimer’s Treatment
Organization UNIVERSITY OF MICHIGAN AT ANN ARBORLocation ANN ARBOR, UNITED STATESPosted 1 Aug 2024Deadline 31 Jul 2029
NIHUS FederalResearch GrantFY2025AD dementiaAD related dementiaADRDAdherenceAducanumabAdverse ExperienceAdverse eventAffectAlzheimer Type DementiaAlzheimer disease dementiaAlzheimer risk factorAlzheimer sclerosisAlzheimer syndromeAlzheimer'sAlzheimer's DiseaseAlzheimer's and related dementiasAlzheimer's dementia and related dementiaAlzheimer's dementia or related dementiaAlzheimer's disease and related dementiaAlzheimer's disease and related disordersAlzheimer's disease or a related dementiaAlzheimer's disease or a related disorderAlzheimer's disease or related dementiaAlzheimer's disease related dementiaAlzheimer's disease riskAlzheimers DementiaAmentiaAmyloidAmyloid SubstanceBIIB037BP reductionBlackBlack PopulationsBlack groupBlack individualBlack peopleBlack raceBlacksBleedingBrainBrain Nervous SystemCare GiversCaregiversCerebral EdemaCerebrumCharacteristicsClinical TrialsCognitive DisturbanceCognitive ImpairmentCognitive declineCognitive function abnormalCoupledDataData BasesData SetDatabasesDecision MakingDementiaDiagnosisDiagnosticDiseaseDisorderDisturbance in cognitionDrugsEffectivenessEncephalonFinancial HardshipFrequenciesGrantHealthHealth CareHealth Insurance for Aged and Disabled, Title 18Health Insurance for Disabled Title 18HemorrhageHigh PrevalenceHospital AdmissionHospitalizationIV InfusionImpaired cognitionImpoverishedIncidenceInfusionInfusion proceduresInterventionInterviewIntravenous infusion proceduresLow Income PopulationLow incomeLow income groupMedicaidMedicareMedicationMethodsMichiganModelingModificationMonitorMonte Carlo MethodMonte Carlo algorithmMonte Carlo calculationMonte Carlo procedureMonte Carlo simulationOut-of-Pocket ExpenseOutcomePatientsPersonsPharmaceutical PreparationsPhasePilot ProjectsPoliciesPopulationPovertyPrevalence StudyPrimary Senile Degenerative DementiaQALYQuality-Adjusted Life ExpectancyQuality-Adjusted Life YearsRacial GroupReportingResearchResearch ResourcesResourcesRiskSeveritiesSurvey InstrumentSurveysTitle 18TransportationUncovered Medical ExpensesUncovered Uninsured Medical ExpenseUninsured Medical ExpenseUnited States Department of Veterans AffairsUnited States Veterans AdministrationVeteransVeterans AdministrationVeterans AffairsVulnerable PopulationsWorkaduhelmalzheimer riskassess effectivenessblood lossblood pressure reductioncerebralcognitive dysfunctioncognitive losscommunity academic collaborationcommunity academic partnershipcommunity academic research partnershipcommunity engagementcommunity university partnershipcomparative cost effectivenesscompare cost effectivenesscostcost effectivenessdata basedementia riskdetermine effectivenessdisparity in caredisparity in healthdisparity in health caredrug/agenteffectiveness assessmenteffectiveness evaluationengagement with communitiesevaluate effectivenessevidence baseexamine effectivenessexperiencefinancial adversityfinancial burdenfinancial distressfinancial insecurityfinancial strainfinancial stresshealth care disparityhealth care inequalityhealth care inequityhealth disparityhealth insurance for disabledhigh riskhigh risk grouphigh risk individualhigh risk peoplehigh risk populationimprovedinfusionsintravenous infusionlow income individuallow income peoplelower BPlower blood pressurelowers blood pressuremedical expenses not covered by insurancemild cognitive disordermild cognitive impairmentmortalityout-of-pocket costsout-of-pocket health care costsparticipant engagementpatient centeredpatient engagementpatient orientedpilot studypreferenceprimary degenerative dementiaracial populationracial subgroupreduce BPreduce blood pressurereduction in BPreduction in blood pressurerisk factor for dementiarisk for dementiascreeningscreeningssenile dementia of the Alzheimer typesuccesstotal medical expenditurevascular risk factorvulnerable groupvulnerable individualvulnerable people
Description preview
Alzheimer’s Disease and Alzheimer’s Disease-Related Dementias (AD/ADRD) are common and increasing across the world. Black and low-income populations have an even higher risk of AD/ADRD than other populations, but despite this higher risk these populations have been less studied. Recently, new anti-amyloid medications have demonstrated impressive…
🔒
Start 7-day free trial — $29.99/mo →Full details available on the Agency plan
Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.
Agency Plan
7-day free trialUnlock procurement & grants
Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.
$29.99 / month
- 🔔Email alerts for new matching tenders
- 🗂️Track tenders in your pipeline
- 💰Filter by contract value
- 📥Export results to CSV
- 📌Save searches with one click